Lung Cancer Clinical Trial
Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound
Summary
All patients undergoing video-assisted thoracoscopic (VATS) resection of lung cancer will receive standard therapy including lobectomy or sub-lobar resection and mediastinal lymph node dissection. After completion of the standard of care, intraoperative ultrasound will be used to evaluate lymph node stations for the presence of any missed lymph nodes with particular focus on lymph nodes which may appear pathologic on ultrasound evaluation. Data will be reviewed for rates of pathologic upstaging, and sensitivity and specificity of ultrasound as an additional diagnostic tool in the operating room will be evaluated. It is hypothesized that Intra-operative thoracoscopic ultrasound following standard video-assisted thoracoscopic (VATS) dissection will increase the rate of pathologically staged in N2 nodes in non-small cell lung cancer patients undergoing definitive surgical resection.
Eligibility Criteria
Inclusion Criteria:
Age ≥18 years. Eastern Cooperative Oncology Group performance status ≤2 (Karnofsky ≥60%, see Appendix A).
Life expectancy of greater than 3 months
Patients be able to undergo VATS resection as defined below:
Preoperative Forced Expiratory Volume at one second ≥ 40% predicted
OR
Post-operative predicted Forced Expiratory Volume at one second ≥ 0.8 l
Hg ≥ 8.0
No evidence of coronary ischemia on stress evaluation Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
Patients with surgery for a prior ipsilateral lung cancer
Patients with known brain metastases
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements. (Patients with HIV are not excluded from this study)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Lexington Kentucky, 40536, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.